Theravance Biopharma Inc. (TBPH)
NASDAQ · Healthcare
Theravance Biopharma Inc. Shareholder Equity 2012–2025
Theravance Biopharma Inc. annual shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Theravance Biopharma Inc. shareholder equity as of December 31, 2025: 296.7M, a 69.03% increase year-over-year.
- Theravance Biopharma Inc. shareholder equity for 2025 were 296.7M, a 69.03% increase from 2024.
- Theravance Biopharma Inc. shareholder equity for 2024 were 175.5M, a 17.58% decrease from 2023.
- Theravance Biopharma Inc. shareholder equity for 2023 were 213.0M, a 51.79% decrease from 2022.
- Theravance Biopharma Inc. shareholder equity for 2022 were 441.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Theravance Biopharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $297 |
| 2024 | $176 |
| 2023 | $213 |
| 2022 | $442 |
| 2021 | $-339 |
| 2020 | $-304 |
| 2019 | $-224 |
| 2018 | $-52 |
| 2017 | $115 |
| 2016 | $350 |
| 2015 | $243 |
| 2014 | $290 |
| 2013 | $-17 |
Theravance Biopharma Inc. Shareholder Equity — FAQ
Theravance Biopharma Inc. (TBPH) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TBPH's shareholder equity history?
The chart and table above show Theravance Biopharma Inc.'s shareholder equity by year and by quarter, including the growth rate.